A major trial finds the beta blocker bisoprolol neither improves nor worsens outcomes in people with COPD, despite the cardiovascular risk.

The National Institute for Health and Care Excellence (NICE), has published final draft guidance recommending dupilumab as a ...

ENA Respiratory Announces Dosing of First Participants in Phase II Study of INNA-051 Nasal Spray Designed to Protect Against Symptomatic Viral Respiratory InfectionsMelbourne, Australia, 29 January ...

Expect a high of 14 degrees that feels more like 12, with an overnight low of -2. Forecasters predict it will be frigid with ...

Respiratory researchers are set to investigate a surprising driver of poor lung health: the body's metabolism.University of ...

Here are a few tips on how to stay warm this weekend, along with suggested thermostat setting, and protecting your plants, ...

An 81 year old woman laughed after believing her family had smuggled her favourite brandy into hospital during her final days. Jennifer Anita Green, known as Nanna Jenny, was receiving end of life ...

The acquisition will strengthen GSK’s immunology pipeline, which is a key area of focus for the pharma company.

There has been a lasting and disproportionate impact of the Covid-19 pandemic on diagnosis rates for conditions including ...

The Phase 1/2 trial is a first-in-human, open-label, multi-national study designed to evaluate the safety, tolerability, and efficacy of TSRA-196 in adults with AATD. Trial participants will receive a ...

We often think of ourselves as more capable than we really are. For example, according to this survey, four in five Americans ...

AstraZeneca Canada is pleased to announce that Tagrisso® (osimertinib) and Calquence® (acalabrutinib tablets) are now ...